Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2015-04-15

Clinical Trial Update: Physician Liver Function Test (LFT) Monitoring for Tykerb Pts

View source ↗

Summary

An update outlining liver function test (LFT) monitoring requirements for patients treated with Tykerb (lapatinib) in cancer trials. It emphasizes safety survei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tykerb (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Status: COMPLETED